These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 26143926)
41. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors. Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644 [TBL] [Abstract][Full Text] [Related]
42. A structural atlas of kinases inhibited by clinically approved drugs. Wang Q; Zorn JA; Kuriyan J Methods Enzymol; 2014; 548():23-67. PubMed ID: 25399641 [TBL] [Abstract][Full Text] [Related]
43. Role of salt bridge dynamics in inter domain recognition of human IMPDH isoforms: an insight to inhibitor topology for isoform-II. Bairagya HR; Mukhopadhyay BP; Bera AK J Biomol Struct Dyn; 2011 Dec; 29(3):441-62. PubMed ID: 22066532 [TBL] [Abstract][Full Text] [Related]
44. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design. Krajewski WW; Collins R; Holmberg-Schiavone L; Jones TA; Karlberg T; Mowbray SL J Mol Biol; 2008 Jan; 375(1):217-28. PubMed ID: 18005987 [TBL] [Abstract][Full Text] [Related]
46. Conformational differences among solution structures of the type Ialpha, IIalpha and IIbeta protein kinase A regulatory subunit homodimers: role of the linker regions. Vigil D; Blumenthal DK; Heller WT; Brown S; Canaves JM; Taylor SS; Trewhella J J Mol Biol; 2004 Apr; 337(5):1183-94. PubMed ID: 15046986 [TBL] [Abstract][Full Text] [Related]
47. Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases. Lavogina D; Lust M; Viil I; König N; Raidaru G; Rogozina J; Enkvist E; Uri A; Bossemeyer D J Med Chem; 2009 Jan; 52(2):308-21. PubMed ID: 19143565 [TBL] [Abstract][Full Text] [Related]
48. Development of phosphocellulose paper-based screening of inhibitors of lipid kinases: case study with PI3Kβ. Yanamandra M; Kole L; Giri A; Mitra S Anal Biochem; 2014 Mar; 449():132-8. PubMed ID: 24380788 [TBL] [Abstract][Full Text] [Related]
49. Localization and projected role of phosphatidylinositol 4-kinases IIα and IIβ in inositol 1,4,5-trisphosphate-sensitive nucleoplasmic Ca²⁺ store vesicles. Yoo SH; Huh YH; Huh SK; Chu SY; Kim KD; Hur YS Nucleus; 2014; 5(4):341-51. PubMed ID: 25482123 [TBL] [Abstract][Full Text] [Related]
52. New Amidated 3,6-Diphenylated Imidazopyridazines with Potent Antiplasmodium Activity Are Dual Inhibitors of Cheuka PM; Centani L; Arendse LB; Fienberg S; Wambua L; Renga SS; Dziwornu GA; Kumar M; Lawrence N; Taylor D; Wittlin S; Coertzen D; Reader J; van der Watt M; Birkholtz LM; Chibale K ACS Infect Dis; 2021 Jan; 7(1):34-46. PubMed ID: 33319990 [TBL] [Abstract][Full Text] [Related]
53. Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology. Mejdrová I; Chalupská D; Plačková P; Müller C; Šála M; Klíma M; Baumlová A; Hřebabecký H; Procházková E; Dejmek M; Strunin D; Weber J; Lee G; Matoušová M; Mertlíková-Kaiserová H; Ziebuhr J; Birkus G; Boura E; Nencka R J Med Chem; 2017 Jan; 60(1):100-118. PubMed ID: 28004945 [TBL] [Abstract][Full Text] [Related]
54. A homogeneous and nonisotopic assay for phosphatidylinositol 4-kinases. Tai AW; Bojjireddy N; Balla T Anal Biochem; 2011 Oct; 417(1):97-102. PubMed ID: 21704602 [TBL] [Abstract][Full Text] [Related]
55. Understanding the selectivity of inhibitors toward PI4KIIIα and PI4KIIIβ based molecular modeling. Tian S; Zeng J; Liu X; Chen J; Zhang JZH; Zhu T Phys Chem Chem Phys; 2019 Oct; 21(39):22103-22112. PubMed ID: 31570909 [TBL] [Abstract][Full Text] [Related]
56. Structural Analysis of Inhibitor Binding to CAMKK1 Identifies Features Necessary for Design of Specific Inhibitors. Santiago ADS; Couñago RM; Ramos PZ; Godoi PHC; Massirer KB; Gileadi O; Elkins JM Sci Rep; 2018 Oct; 8(1):14800. PubMed ID: 30287839 [TBL] [Abstract][Full Text] [Related]
57. Human phosphatidylinositol 4-kinase isoform PI4K92. Expression of the recombinant enzyme and determination of multiple phosphorylation sites. Suer S; Sickmann A; Meyer HE; Herberg FW; Heilmeyer LM Eur J Biochem; 2001 Apr; 268(7):2099-106. PubMed ID: 11277933 [TBL] [Abstract][Full Text] [Related]
58. Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2. Silva-Santisteban MC; Westwood IM; Boxall K; Brown N; Peacock S; McAndrew C; Barrie E; Richards M; Mirza A; Oliver AW; Burke R; Hoelder S; Jones K; Aherne GW; Blagg J; Collins I; Garrett MD; van Montfort RL PLoS One; 2013; 8(6):e65689. PubMed ID: 23776527 [TBL] [Abstract][Full Text] [Related]
59. Probing the Architecture, Dynamics, and Inhibition of the PI4KIIIα/TTC7/FAM126 Complex. Dornan GL; Dalwadi U; Hamelin DJ; Hoffmann RM; Yip CK; Burke JE J Mol Biol; 2018 Sep; 430(18 Pt B):3129-3142. PubMed ID: 30031006 [TBL] [Abstract][Full Text] [Related]
60. Genomic tagging reveals a random association of endogenous PtdIns5P 4-kinases IIalpha and IIbeta and a partial nuclear localization of the IIalpha isoform. Wang M; Bond NJ; Letcher AJ; Richardson JP; Lilley KS; Irvine RF; Clarke JH Biochem J; 2010 Sep; 430(2):215-21. PubMed ID: 20569199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]